Literature DB >> 18485983

Is superficial spreading melanoma still the most common form of malignant melanoma?

Seth B Forman1, Tammie C Ferringer, Steven J Peckham, Scott R Dalton, Geoff T Sasaki, Lester F Libow, Dirk M Elston.   

Abstract

BACKGROUND: Most epidemiological studies suggest that superficial spreading melanoma is the most common histological subtype of malignant melanoma, but past data may not reflect current patterns of sun exposure or other risk factors.
OBJECTIVE: We sought to determine the prevalence of melanoma subtypes among recent specimens in a South Texas dermatopathology practice.
RESULTS: Lentigo maligna was the most common subtype of melanoma among the cases studied. Of 771 cases of melanoma reviewed, lentigo maligna and lentigo maligna melanoma accounted for 429 (56%). There were 220 cases of pagetoid (superficial spreading) melanoma (29%). Nodular melanoma with no apparent radial growth phase accounted for 27 cases (4%), and there were 23 cases of acral lentiginous melanoma (3%). The remaining 72 specimens (9%) included cutaneous metastases, spitzoid melanoma, melanoma in situ arising within a nevus, nevoid melanoma, desmoplastic melanoma, and patterns that could not be classified. LIMITATIONS: Although the dermatopathology practice is located in South Texas, most patients are active duty military, military retirees, and military dependents. The majority currently resides in Texas, but the patients have lived in many locations around the world and traveled extensively. Sun exposure patterns and other risk factors may not reflect those of other populations. We were not able to perform subgroup analysis based on ethnicity or skin type as such data were not typically submitted with the specimens.
CONCLUSION: Our results challenge the notion that pagetoid (superficial spreading) melanoma is the most common subtype of malignant melanoma, at least in patients with extensive sun exposure. Changing patterns of sun exposure or environmental factors may contribute to the changing epidemiology of malignant melanoma. The current prevalence of subtypes of melanoma should be studied in other populations.

Entities:  

Mesh:

Year:  2008        PMID: 18485983     DOI: 10.1016/j.jaad.2007.10.650

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  12 in total

1.  Dermal changes in superficial basal cell carcinoma, melanoma in situ and actinic keratosis and their implications.

Authors:  Viktoryia Kazlouskaya; Saurabh Malhotra; Raquel Navarro; Karen Nguyen Wu; Marianna Shvartsbeyn; Chen Shengli; Jiang Gui; Dirk M Elston
Journal:  J Cutan Pathol       Date:  2013-10-03       Impact factor: 1.587

2.  MNK1/2 inhibition limits oncogenicity and metastasis of KIT-mutant melanoma.

Authors:  Yao Zhan; Jun Guo; William Yang; Christophe Goncalves; Tomasz Rzymski; Agnieszka Dreas; Eliza Żyłkiewicz; Maciej Mikulski; Krzysztof Brzózka; Aniela Golas; Yan Kong; Meng Ma; Fan Huang; Bonnie Huor; Qianyu Guo; Sabrina Daniela da Silva; Jose Torres; Yutian Cai; Ivan Topisirovic; Jie Su; Krikor Bijian; Moulay A Alaoui-Jamali; Sidong Huang; Fabrice Journe; Ghanem E Ghanem; Wilson H Miller; Sonia V Del Rincón
Journal:  J Clin Invest       Date:  2017-10-16       Impact factor: 14.808

3.  Genetics and genomics of melanoma.

Authors:  Papia Ghosh; Lynda Chin
Journal:  Expert Rev Dermatol       Date:  2009-04-01

4.  Histopathology report of cutaneous melanoma and sentinel lymph node in Europe: a web-based survey by the Dermatopathology Working Group of the European Society of Pathology.

Authors:  Anna Batistatou; Martin G Cook; Daniela Massi
Journal:  Virchows Arch       Date:  2009-04-08       Impact factor: 4.064

5.  Distribution of MC1R variants among melanoma subtypes: p.R163Q is associated with lentigo maligna melanoma in a Mediterranean population.

Authors:  J A Puig-Butillé; C Carrera; R Kumar; Z Garcia-Casado; C Badenas; P Aguilera; J Malvehy; E Nagore; S Puig
Journal:  Br J Dermatol       Date:  2013-10       Impact factor: 9.302

Review 6.  Biophysical characterization of melanoma cell phenotype markers during metastatic progression.

Authors:  Anna Sobiepanek; Alessio Paone; Francesca Cutruzzolà; Tomasz Kobiela
Journal:  Eur Biophys J       Date:  2021-03-17       Impact factor: 1.733

7.  Epidemiological aspects of melanoma at a university hospital dermatology center over a period of 20 years.

Authors:  Flavia Vieira Brandão; Ana Francisca Junqueira Ribeiro Pereira; Bernardo Gontijo; Flávia Vasques Bittencourt
Journal:  An Bras Dermatol       Date:  2013 May-Jun       Impact factor: 1.896

8.  Dermatoscopic features of cutaneous non-facial non-acral lentiginous growth pattern melanomas.

Authors:  Jeff Keir
Journal:  Dermatol Pract Concept       Date:  2014-01-31

Review 9.  Perspectives on the application of nanotechnology in photodynamic therapy for the treatment of melanoma.

Authors:  Victoria Monge-Fuentes; Luis Alexandre Muehlmann; Ricardo Bentes de Azevedo
Journal:  Nano Rev       Date:  2014-09-01

10.  Rad6 is a Potential Early Marker of Melanoma Development.

Authors:  Karli Rosner; Shreelekha Adsule; Brittany Haynes; Evangelia Kirou; Ikuko Kato; Darius R Mehregan; Malathy P V Shekhar
Journal:  Transl Oncol       Date:  2014-05-12       Impact factor: 4.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.